Streetbeat News

Products Services

NEXNF

NEXE Innovations Inc has expanded its distribution through a partnership with ecoBeans Coffee, delivering compostable coffee pods to enhance its presence in retail and office coffee services.

Portfolio Pulse from

November 14, 2024 | 4:00 pm

BBIO

BridgeBio Pharma, Inc. is awaiting an FDA decision on its drug acoramidis for transthyretin amyloidosis, with strong clinical data suggesting likely approval. The decision is expected on November 29th. Despite past setbacks, recent data shows significant improvements, and the company has secured funding and partnerships. However, commercial success is uncertain due to competition from Pfizer and Alnylam.

Portfolio Pulse from

November 14, 2024 | 4:00 pm

GIS

Pillsbury, a leading brand in holiday baking, hosted the 52nd Pillsbury Bake-Off™ Contest with Donna Kelce. The event celebrated home bakers and awarded a $50,000 grand prize to Julie McIntire.

Portfolio Pulse from

November 14, 2024 | 4:00 pm

BA

TXT

Bell-Boeing, a joint venture between Boeing (BA) and Bell Helicopter (a unit of Textron (TXT)), has secured a contract to support the CMV-22 Osprey aircraft program.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

NGNE

Levi & Korsinsky has initiated an investigation into Neurogene Inc. (NASDAQ:NGNE) for potential violations of federal securities laws. This follows a press release by Neurogene reporting interim clinical data from a Phase 1/2 trial of NGN-401 gene therapy for Rett syndrome.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

SONO

Sonos reported a narrower-than-expected loss for Q4, despite a year-over-year decline in revenues due to delays in product launches and setbacks with a new app rollout. The stock price jumped following the announcement.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

GOOG

Alphabet (GOOG) is facing increased competition in the global search engine market, which may impact its market dominance and stock performance.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

AMZN

HIMS

Amazon has introduced fixed pricing for Prime members to treat conditions such as hair loss and erectile dysfunction, directly competing with companies like Hims & Hers Health. This announcement led to a 15% drop in Hims & Hers stock.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

MYGN

Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential violations of federal securities laws. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test starting January 1, 2025.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

IPWR

Ideal Power Inc (NASDAQ:IPWR) reported progress in its B-TRAN semiconductor commercialization during Q3 2024, ending the quarter with $18.7 million in cash and no long-term debt. The company is focusing on strategic partnerships in the automotive sector to replace traditional contactors with B-TRAN solutions.

Portfolio Pulse from

November 14, 2024 | 3:30 pm